Breaking News, Collaborations & Alliances

SK pharmteco, Lotte Biologics Partner to Strengthen Global ADC CDMO Capabilities

Will deliver integrated, one-stop CDMO services spanning antibody drug substance, linker–payload production, and bioconjugation.

Author Image

By: Charlie Sternberg

Associate Editor

Leaders from SK pharmteco and Lotte Biologics at CPHI Frankfurt, Germany.

SK pharmteco and Lotte Biologics have signed a Letter of Intent (LOI) for a strategic collaboration to strengthen their competitiveness in the global antibody-drug conjugate (ADC) market. Through this collaboration, the two companies will jointly investigate providing integrated, one-stop CDMO services to global clients, offering differentiated ADC solutions that span from development to commercial manufacturing. Lotte Biologics will utilize its cGMP manufacturing capabilities and global q...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters